DBV Technologies S.A.

Symbol: DBVT

NASDAQ

0.5705

USD

Market price today

  • -690.3949

    P/E Ratio

  • -96.1621

    PEG Ratio

  • 109.73M

    MRK Cap

  • 0.00%

    DIV Yield

DBV Technologies S.A. (DBVT) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

1.60%

Operating Profit Margin

-3.10%

Net Profit Margin

-5.86%

Return on Assets

-0.54%

Return on Equity

-0.90%

Return on Capital Employed

-0.35%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Daniel Tassé
Full-time employees:104
City:Montrouge
Address:177-181 Avenue Pierre Brossolette
IPO:2014-10-22
CIK:0001613780

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

General Outlook

When we look at how much money they make before expenses, they keep 1.600% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -3.104%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -5.860%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.545% return, is a testament to DBV Technologies S.A.'s adeptness in optimizing resource deployment. DBV Technologies S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.897%. Furthermore, the proficiency of DBV Technologies S.A. in capital utilization is underscored by a remarkable -0.353% return on capital employed.

Stock Prices

DBV Technologies S.A.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.69, while its low point bottomed out at $0.6515. This variance in figures offers investors a lucid insight into the roller-coaster ride that is DBV Technologies S.A.'s stock market.

Liquidity Ratios

Analyzing DBVT liquidity ratios reveals its financial health of the firm. The current ratio of 451.47% gauges short-term asset coverage for liabilities. The quick ratio (383.36%) assesses immediate liquidity, while the cash ratio (383.36%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio451.47%
Quick Ratio383.36%
Cash Ratio383.36%

Profitability Ratios

DBVT profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -614.93% underscores its earnings before tax deductions. The effective tax rate stands at 4.63%, revealing its tax efficiency. The net income per EBT, 95.29%, and the EBT per EBIT, 198.14%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -310.35%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-614.93%
Effective Tax Rate4.63%
Net Income per EBT95.29%
EBT per EBIT198.14%
EBIT per Revenue-310.35%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.51, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding383
Fixed Asset Turnover0.70
Asset Turnover0.09

Cash Flow Ratios

Lastly, the operating cash flow sales ratio, -6.89, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow Sales Ratio-6.89
Free Cash Flow to Operating Cash Flow Ratio1.01
Capital Expenditure Coverage Ratio-165.20
Dividend Paid and Capex Coverage Ratio-165.20

Debt and Leverage Ratios

An interest coverage of 1.85 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage1.85
Company Equity Multiplier1.31

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.08, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.38, reflects the portion of profit attributed to each share. The book value per share, 0.74, represents the net asset value distributed per share, while the tangible book value per share, 0.74, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.08
Net Income Per Share-0.38
Book Value Per Share0.74
Tangible Book Value Per Share0.74
Shareholders Equity Per Share0.74
Interest Debt Per Share0.08

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 227.67%, indicates top-line expansion, while the gross profit growth, 222.32%, reveals profitability trends. EBIT growth, 4.63%, and operating income growth, 4.63%, offer insights into operational profitability progression. The net income growth, 24.48%, showcases bottom-line expansion, and the EPS growth, 38.71%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth227.67%
Gross Profit Growth222.32%
EBIT Growth4.63%
Operating Income Growth4.63%
Net Income Growth24.48%
EPS Growth38.71%
EPS Diluted Growth38.71%
Weighted Average Shares Growth22.92%
Weighted Average Shares Diluted Growth22.92%
Operating Cash Flow Growth-43.00%
Free Cash Flow Growth-42.29%
10-Year Revenue Growth per Share347.74%
3-Year Revenue Growth per Share-20.68%
10-Year Operating CF Growth per Share68.90%
5-Year Operating CF Growth per Share92.25%
3-Year Operating CF Growth per Share72.65%
10-Year Net Income Growth per Share80.50%
5-Year Net Income Growth per Share94.18%
3-Year Net Income Growth per Share74.08%
10-Year Shareholders Equity Growth per Share-82.04%
5-Year Shareholders Equity Growth per Share-84.64%
3-Year Shareholders Equity Growth per Share-61.21%
Receivables Growth37.91%
Inventory Growth100.00%
Asset Growth-25.77%
Book Value per Share Growth-41.36%
Debt Growth43.47%
R&D Expense Growth-2.14%
SGA Expenses Growth-12.06%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 54,277,320.784, captures the company's total value, considering both debt and equity. Income quality, 1.10, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 1.88, gauges operational efficiency, while the research and development to revenue, 469.74%, highlights investment in innovation. The ratio of intangibles to total assets, 0.03%, indicates the value of non-physical assets, and capex to operating cash flow, 0.85%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value54,277,320.784
Income Quality1.10
Sales General and Administrative to Revenue1.88
Research and Development to Revenue469.74%
Intangibles to Total Assets0.03%
Capex to Operating Cash Flow0.85%
Capex to Revenue-4.30%
Capex to Depreciation15.05%
Stock-Based Compensation to Revenue38.27%
Graham Number2.52
Return on Tangible Assets-39.76%
Graham Net Net0.58
Working Capital121,576,000
Tangible Asset Value140,128,000
Net Current Asset Value116,115,000
Average Receivables13,322,000
Average Payables18,887,500
Average Inventory-5,600,000
Days Sales Outstanding358
Days Payables Outstanding-1891
ROIC-53.22%
ROE-0.52%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 491.41, and the price to book ratio, 491.41, reflect the market's valuation relative to the company's book value. The price to sales ratio, 8.09, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -1.17, and price to operating cash flows, -586.80, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio491.41
Price to Book Ratio491.41
Price to Sales Ratio8.09
Price Cash Flow Ratio-586.80
Price Earnings to Growth Ratio-96.16
Enterprise Value Multiple-2.87
Price Fair Value491.41
Price to Operating Cash Flow Ratio-586.80
Price to Free Cash Flows Ratio-1.17
Price to Tangible Book Ratio1.29
Enterprise Value to Sales3.45
Enterprise Value Over EBITDA-0.56
EV to Operating Cash Flow-0.68
Earnings Yield-40.12%
Free Cash Flow Yield-44.32%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of DBV Technologies S.A. (DBVT) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -690.395 in 2024.

What is the ticker symbol of DBV Technologies S.A. stock?

The ticker symbol of DBV Technologies S.A. stock is DBVT.

What is company IPO date?

IPO date of DBV Technologies S.A. is 2014-10-22.

What is company current share price?

Current share price is 0.571 USD.

What is stock market cap today?

The market cap of stock today is 109731974.000.

What is PEG ratio in 2024?

The current -96.162 is -96.162 in 2024.

What is the number of employees in 2024?

In 2024 the company has 104.